Keywords: sandoz, gets, fda, approval, omnitrope, generics, division

Sandoz gets FDA approval for Omnitrope

Article | 08 September 2008

Print This

Sandoz, the generics division of Swiss drug major Novartis, has received US Food and Drug Administration approval for its Omnitrope ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in